Progenics Pharmaceuticals Announces Third Quarter 2016 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. PCG
2. NVDA
3. APO
4. BRVE
5. OKE
6. SRE
7. CNS
8. HDB
9. ATTO
10. EIX

Go back to Progenics Pharmaceuticals Announces Third Quarter 2016 Financial Results and Business Update

Progenics Pharma (PGNX) Misses Q3 EPS by 3c

November 7, 2016 7:56 AM EST

Progenics Pharma (NASDAQ: PGNX) reported Q3 EPS of $0.52, $0.03 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $53.9 million versus the consensus estimate of $52.9 million.

For earnings history and earnings-related data on Progenics Pharma (PGNX) click here.

... More